Anti-PBM sentiment continues to rise, but industry observers still question whether the reforms being discussed will be effective.

Despite GOP criticism of the Part D stabilization program and its budgetary impact, the Trump Administration may decide to keep it in part to avoid blame for a premium increase.

In the proposed rule, CMS said it would begin reviewing Part D plan formularies and utilization practices to see if programs include incentives to reduce costs, as well as offered suggestions for implementing the new Medicare Prescription Payment Plan.

The motive for the shocking murder of Brian Thompson in New York City was still unknown Wednesday afternoon.

The motive for the shocking murder of Brian Thompson in New York City was still unknown Wednesday afternoon.

Scant evidence has emerged proving that carving out retail pharmacy benefit management from Medicaid managed care organization contracts helps limit costs.